Status of COVID-19 Medicines and Active Pharmaceutical Ingredients (APIs) updated M Announcement 20 January, 2023 - 10:00 (CET)
Newly prequalified Active Pharmaceutical Ingredient (API) M Announcement 19 January, 2023 - 13:00 (CET) Flucytosine (WHOAPI-406) manufactured by Solara Active Pharma Sciences Limited, has been prequalified by the
WHO list of SARS-CoV-2 IVDs currently under assessment for Emergency Use Listing updated IVD Announcement 17 January, 2023 - 22:00 (CET)
IVD newsletter, Q4 2022 - Issue 40 published IVD Alerts 17 January, 2023 - 17:50 (CET) IVD newsletter - Q4 2022 - Issue 40
Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process updated V Announcement 12 January, 2023 - 17:10 (CET)
WHO list of SARS-CoV-2 IVDs currently under assessment for Emergency Use Listing updated IVD Announcement 10 January, 2023 - 02:00 (CET)
WHO list of SARS-CoV-2 IVDs currently under assessment for Emergency Use Listing updated IVD Announcement 3 January, 2023 - 02:00 (CET)